Scholars@Duke
Jeffrey Washam

Jeffrey Washam

Clinical Affiliate in the Department of Medicine
Medicine, Clinical Pharmacology
jeff.washam@duke.edu
Box 3943 Med Ctr, Durham, NC
7724 Duke North, Durham, NC 27710

Scholarly Works - Conferences

Efficacy and Safety of Rivaroxaban Versus Warfarin in Patients Taking Nondihydropyridine Calcium Channel Blockers for Atrial Fibrillation (from the ROCKET AF Trial).

Conference Am J Cardiol · August 15, 2017 Non-dihydropyridine calcium channel blockers (non-DHP CCBs) possess combined P-glycoprotein and moderate CYP3A4 inhibition, which may lead to increased exposure of medications that are substrates for these metabolic pathways, such as rivaroxaban. We evalua ... Full text Link to item Cite